Connect your AI

LivaNova LIVN Total Liabilities & Equity

Total Liabilities & Equity at other companies

AbbottABT

$110.43B+35.6%

HaemoneticsHAE

$2.4B-2.2%

MedtronicMDT

$93.03B+1.5%

ITG

Integer HoldingsITGR

$3.41B+3.5%

ResMedRMD

$8.78B+16.1%

Boston ScientificBSX

$44.35B+10.5%

Other financials

Income statement

Revenue$362.3M+14.3%

Gross profit$243.7M+12.7%

Operating income$41.5M-14.7%

Net income$22.3M+107%

EPS (diluted)$0.40+107%

Balance sheet

Cash & equivalents$539.7M-26.9%

Total debt$340.9M-49.7%

Total equity$1.2B+17.1%

Total assets$2.5B-1.7%

Cash flow

Operating cash flow$15.2M-36.5%

CapEx$14.3M+32.4%

Free cash flow$926.0K-93.0%

Valuation

Market cap$4.32B+62.8%

Profitability

Gross margin67.5%-0.5pp

Operating margin13.4%+0.8pp

Net margin-16.1%-18.0pp

FCF margin11.2%-0.2pp

Returns & leverage

Return on equity-17.6%-19.5pp

Debt / equity0.3×-0.4×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LivaNova's total liabilities & equity?: LivaNova (LIVN) reported total liabilities & equity of $2.52B in Q1 2026.
How has LivaNova's total liabilities & equity changed year-over-year?: LivaNova's total liabilities & equity decreased by 1.7% year-over-year, from $2.56B to $2.52B.
What is the long-term trend for LivaNova's total liabilities & equity?: Over 5 years (2020 to 2025), LivaNova's total liabilities & equity has grown at a 1.7% compound annual growth rate (CAGR), from $2.4B to $2.61B.
What does total liabilities & equity mean?: Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.